Platinum Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Platinum Investment Management’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-13,820	Closed	-$1.18M	–	101
2019 Q2	$1.18M	Hold	13,820	–	–	0.03%	80
2019 Q1	$1.23M	Hold	13,820	–	–	0.03%	81
2018 Q4	$1.18M	Hold	13,820	–	–	0.04%	69
2018 Q3	$1.34M	Hold	13,820	–	–	0.04%	64
2018 Q2	$1.3M	Hold	13,820	–	–	0.03%	65
2018 Q1	$1.12M	Hold	13,820	–	–	0.03%	69
2017 Q4	$1.23M	Hold	13,820	–	–	0.03%	62
2017 Q3	$1.29M	Hold	13,820	–	–	0.03%	60
2017 Q2	$1.25M	Hold	13,820	–	–	0.03%	59
2017 Q1	$1.21M	Hold	13,820	–	–	0.03%	60
2016 Q4	$1.14M	Hold	13,820	–	–	0.03%	58
2016 Q3	$1.28M	Sell	13,820 -3,400	-20%	-$320K	0.03%	63
2016 Q2	$1.34M	Hold	17,220	–	–	0.03%	58
2016 Q1	$1.42M	Hold	17,220	–	–	0.03%	60
2015 Q4	$1.8M	Sell	17,220 -4,000	-19%	-$418K	0.04%	53
2015 Q3	$2.23M	Hold	21,220	–	–	0.06%	46
2015 Q2	$2.9M	Hold	21,220	–	–	0.06%	49
2015 Q1	$2.64M	Sell	21,220 -12,300	-37%	-$1.3M	0.05%	59
2014 Q4	$3.03M	Hold	33,520	–	–	0.06%	63
2014 Q3	$2.42M	Buy	33,520 +7,000	+26%	+$460K	0.05%	60
2014 Q2	$1.65M	Buy	26,520 +18,000	+211%	+$1.09M	0.03%	70
2014 Q1	$581K	Hold	8,520	–	–	0.01%	87
2013 Q4	$599K	Hold	8,520	–	–	0.01%	82
2013 Q3	$614K	Hold	8,520	–	–	0.01%	78
2013 Q2	$474K	Buy	+8,520	New	+$531K	0.01%	73

Other funds holding BMRN

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Platinum Investment Management's BMRN Position: Q3 2019 in Review

Platinum Investment Management sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2019, closing a stake of 13,820 shares — an estimated $1.18M sold.

Platinum Investment Management first reported a position in BMRN in Q2 2013 and held it in 25 quarters. The position peaked at $3.03M in Q4 2014. 437 funds tracked by Wall St. Rank hold BMRN as of Q3 2019.

Platinum Investment Management reported no remaining BioMarin Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Platinum Investment Management sold 13,820 BioMarin Pharmaceuticals shares in Q3 2019, an estimated $1.18M.
Platinum Investment Management first reported a position in BioMarin Pharmaceuticals in Q2 2013 and held it in 25 quarters.
Platinum Investment Management's BioMarin Pharmaceuticals position peaked at $3.03M in Q4 2014.
437 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2019.

Based on Platinum Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.